45 minutes
At its core, digital technologies are increasingly critical in enabling the growth of biotechnology companies– from the development of better research and development insight engines, to the commercialization of next generation therapies via digital channels. This panel will explore best practices that enable the embedding of digital health technologies in the value chain for both life sciences companies, payers and providers.


Anthony Uzzo - Vice President, Product Management and Platform Strategy, ThermoFisher
Hussain Mooraj - Next Gen Therapy Practice Lead, Deloitte
Jeff Elton - CEO, Concerto HealthAI
Luba Greenwood - Managing Partner, Binney Street Capital, CEO, Kojin Therapeutics Senior Lecturer, Harvard University
Name Audience
Conference Wide